Literature DB >> 8853252

Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.

I L Beales1, J E Crabtree, D Scunes, A Covacci, J Calam.   

Abstract

Strains of Helicobacter pylori which express the product of the cytotoxin associated gene A(CagA) are associated with duodenal ulceration. Also there is evidence that the presence of serum IgG antibodies to CagA is associated with an increased risk of gastric cancer of the intestinal type. Gastric atrophy is a precursor of intestinal-type gastric cancer so we have investigated whether antibodies to CagA are associated with gastric atrophy. In H. pylori infected patients, IgG antibodies to CagA were present in 24/38 (63%) of non-ulcer patients with atrophy compared with 13/40 (33%) of patient-controls with neither atrophy nor ulcer (P < 0.02). CagA antibodies were also more prevalent in patients with duodenal ulcers; 15/20 (75%) or gastric ulcers 5/5 (100%) than in the patient-controls (P < 0.005 and < 0.02 respectively). These results show that circulating IgG antibodies to CagA are associated with gastric atrophy, as well as peptic ulcer disease. Atrophy is a precursor of gastric cancer so support the hypothesis that certain strains of H. pylori are more likely to cause gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8853252

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  28 in total

1.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Evaluation of the role of H pylori infection in pathogenesis of gastric cancer by immunoblot assay.

Authors:  Kuo-Ching Yang; Alexander Chu; Chao-Sheng Liao; Yu-Min Lin; Gen-Min Wang
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

3.  Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

4.  CagA antibodies in Japanese children with nodular gastritis or peptic ulcer disease.

Authors:  S Kato; T Sugiyama; M Kudo; K Ohnuma; K Ozawa; K Iinuma; M Asaka; M J Blaser
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis.

Authors:  V J Warburton; S Everett; N P Mapstone; A T Axon; P Hawkey; M F Dixon
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

6.  Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection.

Authors:  R Carratù; D Iuliano; M R Iovene; F Ferraraccio; P Esposito; M I Russo; F Montella; G Abbate; M A Tufano
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

7.  Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes.

Authors:  L J van Doorn; C Figueiredo; R Sanna; M J Blaser; W G Quint
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 8.  Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  Expanding allelic diversity of Helicobacter pylori vacA.

Authors:  L J van Doorn; C Figueiredo; R Sanna; S Pena; P Midolo; E K Ng; J C Atherton; M J Blaser; W G Quint
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  IgG subclass response to Helicobacter pylori and CagA antigens in children.

Authors:  K Dzierzanowska-Fangrat; M Raeiszadeh; D Dzierzanowska; M Gladkowska-Dura; D Celinska-Cedro; J E Crabtree
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.